This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hang Back for This One

Of course, the big issue in Europe is that the economies of the nations there are getting weaker, not stronger, as austerity continues to drag them down. We have to expect a further leg down now as capital flows get all mixed up and the weaker countries sustain another shock to their business confidence. That's the more logical takeaway and lasting impact of Cypress -- not runs on the weaker Italian and Spanish banks to put money in Deutsche Bank (DB - Get Report), and not any fleeing from the euro to the pound and the dollar.

Now, we have to recognize that something has changed between the two continents. We are seeing a stable to expanding economy here in the U.S., while Europe remains unstable and in contraction. With the exception of the big international banks, like JPMorgan Chase (JPM - Get Report) and Citigroup (C - Get Report), our banks are much better-capitalized by rigorous standards, as compared with the light touch -- some would say ridiculously light touch -- of the European authorities.

So the spillover is contained, and much more so than it was last year or the year before. In other words, Europe can't take us down one-for-one, but it will continue moving the flows into more domestic companies and small-caps, particularly related to healthcare, regional financials, oil-and-gas and the transports, which have been totally on fire.

Which brings me to the real issue that I fear. The reason I've said I don't want to get to the last 1% to 2% of the rally is precisely because so many stocks are too hot.

Let me give you a sense of what we are up against. Whole sectors of this market have just gone totally parabolic, with a completely unsustainable set of moves that have to be repealed before they can be bought on weakness.

I am thinking here of almost every healthcare and healthcare-related stock, from the major pharmaceuticals that have run so much to the biotechs that are crazy hot to the ancillary-medical-device names and hospitals. The charts of such stocks as Becton Dickinson (BDX) and Stryker (SYK) are insanely overextended.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs